Could a simple additive make C-Section anesthesia safer and faster?

NCT ID NCT07465185

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding dexmedetomidine to the standard spinal anesthetic bupivacaine improves pain relief and recovery for women undergoing planned C-sections. 300 full-term pregnant women will be randomly assigned to receive either bupivacaine alone or bupivacaine plus dexmedetomidine. The goal is to see if the combination provides faster onset and shorter duration of numbness, leading to better recovery quality.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Banha Faculity of Medicine

    RECRUITING

    Banhā, Elqalyoubea,, 13511, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bupivacaine and dexmedetomidine

What this could lead to

If successful, this could lead to a safer, more effective spinal anesthesia option for C-sections, with quicker recovery and fewer side effects.

What could go wrong

This is an early phase 2 trial with 300 participants, so results may not apply to all patients. Adding dexmedetomidine could also cause unexpected side effects like low blood pressure or slow heart rate.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.